Avandia

In 2006, GlaxoSmithKline—the esoteric name for a ubiquitous diabetes treatment brand—took a victory lap after a lengthy report in the New England Journal of Medicine declared its Avandia medication to be the most effective of the three diabetes drugs tested. Unfortunately for readers and patients, the ...

Medicare Advantage plans weren't successful in recovering reimbursement of payments until a 2012 court decision, In Re: Avandia, where the court found that any private plaintiff could bring a private cause of action, Deane explained. Four years later, in Humana Medical Plan, Inc. v. Western Heritage, the ...

Various strengths of GlaxoSmithKline Plc's diabetes tablets Avandia sit on the shelf for an illustration at Skenderian Apothecary in Cambridge, Massachusetts. (bloomberg). (Bloomberg) -- GlaxoSmithKline Plc and Reckitt Benckiser Group Plc are the only companies to have submitted non-binding bids for ...

Avandia maker GlaxoSmithKline paid billions to settle thousands of lawsuits over its Type 2 diabetes drug. Lawsuits accused the drugmaker of hiding the dangerous side effects of Avandia, including potentially fatal heart problems. In 2011, GSK set aside $3.4 billion to pay for future Avandia litigation and settlement costs.

"Manufacturers have since fulfilled these requirements," the FDA said in Wednesday's notice, and the risk-management measures in place are "no longer necessary to ensure that the benefits of rosiglitazone medicines outweigh their risks." The last time GSK disclosed the Avandia franchise's sales was ...

Three years ago, in one of the more notable drug-safety scandals in recent history, the diabetes drug Avandia was all but banned from use in the United States after researchers found that thousands of people had heart problems after taking it. Today, it is a drug of last resort for people with diabetes who are ...